| Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3 D Chendil, RS Ranga, D Meigooni, S Sathishkumar, MM Ahmed Oncogene 23 (8), 1599-1607, 2004 | 379 | 2004 |
| Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission … R Ossenkoppele, R Smith, N Mattsson-Carlgren, C Groot, A Leuzy, ... JAMA neurology 78 (8), 961-971, 2021 | 171 | 2021 |
| 18F-flortaucipir PET to autopsy comparisons in Alzheimer’s disease and other neurodegenerative diseases DN Soleimani-Meigooni, L Iaccarino, R La Joie, S Baker, V Bourakova, ... Brain 143 (11), 3477-3494, 2020 | 110 | 2020 |
| Association of APOE4 and clinical variability in Alzheimer disease with the pattern of tau-and amyloid-PET R La Joie, AV Visani, OH Lesman-Segev, SL Baker, L Edwards, ... Neurology 96 (5), e650-e661, 2021 | 80 | 2021 |
| Symptomatic amyloid‐related imaging abnormalities in an APOE ε4/ε4 patient treated with aducanumab L VandeVrede, DM Gibbs, M Koestler, R La Joie, PA Ljubenkov, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 12 (1 …, 2020 | 68 | 2020 |
| Tau positron emission tomographic findings in a former US football player with pathologically confirmed chronic traumatic encephalopathy WG Mantyh, S Spina, A Lee, L Iaccarino, D Soleimani-Meigooni, E Tsoy, ... JAMA neurology 77 (4), 517-521, 2020 | 48 | 2020 |
| The role of amyloid PET in imaging neurodegenerative disorders: a review M Chapleau, L Iaccarino, D Soleimani-Meigooni, GD Rabinovici Journal of Nuclear Medicine 63 (Supplement 1), 13S-19S, 2022 | 45 | 2022 |
| Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer’s disease A Strom, L Iaccarino, L Edwards, OH Lesman-Segev, ... Brain 145 (2), 713-728, 2022 | 44 | 2022 |
| Spatial Relationships between Molecular Pathology and Neurodegeneration in the Alzheimer’s Disease Continuum L Iaccarino, R La Joie, L Edwards, A Strom, DR Schonhaut, ... Cerebral Cortex 31 (1), 1-14, 2021 | 37 | 2021 |
| The impact of demographic, clinical, genetic, and imaging variables on tau PET status R Ossenkoppele, A Leuzy, H Cho, CH Sudre, O Strandberg, R Smith, ... European journal of nuclear medicine and molecular imaging 48, 2245-2258, 2021 | 34 | 2021 |
| Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer's continuum: greater tau-PET retention in females L Edwards, R La Joie, L Iaccarino, A Strom, SL Baker, KB Casaletto, ... Neurobiology of Aging 105, 86-98, 2021 | 29 | 2021 |
| Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer’s disease JA Tanner, L Iaccarino, L Edwards, BM Asken, ML Gorno-Tempini, ... Brain 145 (12), 4489-4505, 2022 | 26 | 2022 |
| JC virus granule cell neuronopathy in the setting of chronic lymphopenia treated with recombinant interleukin-7 DN Soleimani-Meigooni, KE Schwetye, MR Angeles, CF Ryschkewitsch, ... Journal of neurovirology 23, 141-146, 2017 | 16 | 2017 |
| Cylindrical coordinate‐based TG‐43U1 parameters for dose calculation around elongated brachytherapy sources SB Awan, SA Dini, M Hussain, D Soleimani‐Meigooni, AS Meigooni Journal of applied clinical medical physics 9 (2), 123-142, 2008 | 16 | 2008 |
| Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts K Provost, L Iaccarino, DN Soleimani-Meigooni, S Baker, L Edwards, ... European journal of nuclear medicine and molecular imaging 48, 2259-2271, 2021 | 14 | 2021 |
| Plasma P-tau181 and P-tau217 in patients with traumatic encephalopathy syndrome with and without evidence of Alzheimer disease pathology BM Asken, JA Tanner, L VandeVrede, WG Mantyh, KB Casaletto, ... Neurology 99 (6), e594-e604, 2022 | 11 | 2022 |
| Pharmacokinetics of 38 Percent Silver Diamine Fluoride in Children H Ellenikiotis, KF Chen, DN Soleimani-Meigooni, ML Rothen, ... Pediatric Dentistry 44 (2), 114-121, 2022 | 10 | 2022 |
| Amyloid and tau‐PET in early‐onset AD: Baseline data from the Longitudinal Early‐onset Alzheimer's Disease Study (LEADS) H Cho, NS Mundada, LG Apostolova, MC Carrillo, R Shankar, AN Amuiri, ... Alzheimer's & Dementia 19, S98-S114, 2023 | 8 | 2023 |
| A volumetric and dosimetric study of LDR brachytherapy prostate implants based on image fusion of ultrasound and computed tomography N Papanikolaou, D Gearheart, T Bolek, A Meigooni, D Meigooni, ... Proceedings of the 22nd Annual International Conference of the IEEE …, 2000 | 5 | 2000 |
| Profiling baseline performance on the Longitudinal Early‐Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection DB Hammers, A Eloyan, A Taurone, M Thangarajah, L Beckett, S Gao, ... Alzheimer's & Dementia 19, S8-S18, 2023 | 4 | 2023 |
